Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica's Operating Leases history spans 7 years, with the latest figure at $373000.0 for Q3 2025.

  • On a quarterly basis, Operating Leases fell 47.24% to $373000.0 in Q3 2025 year-over-year; TTM through Aug 2025 was $373000.0, a 47.24% decrease, with the full-year FY2025 number at $100000.0, down 78.21% from a year prior.
  • Operating Leases hit $373000.0 in Q3 2025 for Biomerica, up from $100000.0 in the prior quarter.
  • Over the last five years, Operating Leases for BMRA hit a ceiling of $1.4 million in Q1 2022 and a floor of $100000.0 in Q2 2025.
  • Historically, Operating Leases has averaged $860307.2 across 5 years, with a median of $901449.0 in 2022.
  • Biggest five-year swings in Operating Leases: grew 6.83% in 2022 and later plummeted 78.21% in 2025.
  • Tracing BMRA's Operating Leases over 5 years: stood at $1.2 million in 2021, then dropped by 22.74% to $901449.0 in 2022, then increased by 3.94% to $937000.0 in 2023, then crashed by 33.19% to $626000.0 in 2024, then plummeted by 40.42% to $373000.0 in 2025.
  • Business Quant data shows Operating Leases for BMRA at $373000.0 in Q3 2025, $100000.0 in Q2 2025, and $193000.0 in Q1 2025.